OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...
Bayer will present three new prespecified subgroup analyses from the pivotal Phase III FINEARTS-HF cardiovascular outcomes trial investigating KERENDI ...
In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...
The flow cytometry-based assay measures the expression of the protein FcyR11a as a biomarker for cardiovascular risk.
A recent study highlights that more than 10.5 hours of daily sedentary behavior is linked to increased risks of heart failure ...
A research team from the Nagoya University Graduate School of Medicine has discovered a promising way to slow the progression ...
Niyondiko, N. (2024) Clinical Management of Diabetic Ketoacidosis in Pregnancy: A Review of Current Literature. Open Access Library Journal, 11, 1-25. doi: 10.4236/oalib.1112246 .
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback